CRCA
ProShares Ultra CRCL
Price Chart
Latest Quote
$16.14
+0.39 (+2.48%)
Current Price
| Previous Close | $15.75 |
| Open | $15.52 |
| Day High | $16.25 |
| Day Low | $15.24 |
| Volume | 282,237 |
Fund Information
| Quarterly Dividend / Yield | N/A / 4.59% |
| Net Assets | $98.56M |
| Expense Ratio | 0.95% |
| Category | Trading--Leveraged Equity |
| Fund Family | ProShares |
| Net Asset Value | $15.71 |
| Premium/Discount | 2.77% |
| Quarterly Dividend Yield | 4.59% |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $17.57 |
| SMA50 | $20.32 |
| SMA200 | $30.17 |
| RSI | 48.36 |
| ATR | 2.3139 |
| Rel Volume | 0.65 |
Performance History
| Week | -12.19% |
| Month | -15.23% |
| Quarter | +42.47% |
| 6 Months | -56.44% |
| YTD | -62.82% |
| Year | -89.36% |
| 10 Years | -92.58% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $16.14 | 282,237 |
| 2026-10-26 | $15.75 | 489,900 |
| 2026-10-23 | $18.36 | 270,600 |
| 2026-10-22 | $18.67 | 630,600 |
| 2026-10-21 | $20.06 | 504,500 |
| 2026-10-20 | $18.38 | 485,500 |
| 2026-10-19 | $16.52 | 246,000 |
| 2026-10-16 | $16.90 | 379,900 |
| 2026-10-15 | $18.98 | 730,500 |
| 2026-10-14 | $16.11 | 583,100 |
| 2026-10-13 | $18.03 | 134,000 |
| 2026-10-12 | $17.93 | 367,700 |
| 2026-10-09 | $18.22 | 569,800 |
| 2026-10-08 | $16.73 | 348,500 |
| 2026-10-07 | $16.71 | 426,500 |
| 2026-10-06 | $18.16 | 259,200 |
| 2026-10-05 | $17.78 | 470,100 |
| 2026-10-02 | $17.00 | 772,600 |
| 2026-10-01 | $17.63 | 440,200 |
| 2026-09-30 | $17.40 | 344,700 |
| 2026-09-29 | $18.10 | 331,600 |
| 2026-09-28 | $19.04 | 381,900 |
About ProShares Ultra CRCL
Under normal circumstances, the fund will invest at least 80% of the fund's assets in, or provide exposure to, financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the daily target. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on CRCA.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.